By AltG Research on behalf of Taponeel Mukherjee & Poornima Vardhan
Eris Lifesciences Ltd is a listed Indian pharmaceutical company and a leading player in the domestic branded formulations market
The amount of funds invested is 30 per cent higher than the July-December 2023 period, the report by industry lobby grouping IVCA and consultancy firm EY said
The New York-based investment firm's results underscore how a long spell of high interest rates has dragged down some aspects of its business while buoying others
Majority of the deal making activity involving India targeted the High Technology sector which totaled $5.8 billion, a 13.2% increase in value from the comparative period last year.
The quarterly data indicates that commercial office assets maintained their leading position, capturing approximately 51% of the total investment volume
PE investments jump by a whopping 154 per cent sequentially in April-June quarter
Special rights will now be cancelled at the time of listing instead of at the time of filing offer document
Continues to be the largest shareholder
Share sales hold breath for government clarity
Founded in 2015 by Akshay Mehrotra and Ashish Goyal, Fibe facilitates consumer finances like healthcare loans, edtech loans, insurance financing, and school fee financing, among others
The ace fund manager was reacting on 'X' to a Business Standard story that quotes a Reserve Bank of India (RBI) data on gross FDI flows into the country in FY24
The number of deals in April stood at 98, which was 56 per cent higher than the year-ago period, the report by EY, a consultancy firm, and industry lobby grouping IVCA said
The company has received sufficient creditor backing for a proposal to delay a bond payment, according to the people familiar who asked not to be identified
Urban Company has announced its fifth Employee Stock Ownership Plan (ESOP) sale, with a total secondary transaction amount of about Rs 203 crore
The total exit value also witnessed a significant increase, reaching US$3.6 billion - a nearly five-fold jump from the previous year's corresponding quarter
A relatively new portfolio management tool allows private equity managers to move assets around more easily, as a way to hold them for longer
"This investment will support CFS's ability to further scale and serve the growing demand for eye care in India both across Tier-I and Tier-II cities," the statement added
The private equity (PE) investments in India dropped by 18 per cent to USD 29.6 billion from a peak value of USD 36 billion in 2022
"The transaction will support NephroPlus in serving the growing demand for high quality, affordable dialysis services across India and other markets in Asia," Singapore-headquartered Quadria said